You have no items in your shopping cart.
On Promotion 
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Unconjugated
90%
76 kDa
1 mg, 100 μg
- Anti-human CTLA-8 / IL-17a (Vunakizumab Biosimilar) [orb2828610]
ELISA, FA, FACS, In vivo
Human
Monoclonal
Unconjugated
20 mg, 5 mg, 1 mg ELISA, FA, FACS, In vivo
Human
Monoclonal
Unconjugated
20 mg, 5 mg, 1 mg- Anti-human CTLA-8 / IL-17a (Perakizumab Biosimilar) [orb2828612]
ELISA, FA, FACS, In vivo
Human
Monoclonal
Unconjugated
20 mg, 5 mg, 1 mg - Anti-human CTLA-8 / IL-17a (Netakimab Biosimilar) [orb2828613]
ELISA, FA, FACS, In vivo
Human
Monoclonal
Unconjugated
20 mg, 5 mg, 1 mg - Anti-human CTLA-8 / IL-17a (Ixekizumab Biosimilar) [orb2828614]
ELISA, FA, FACS, In vivo
Human, Monkey
Monoclonal
Unconjugated
20 mg, 5 mg, 1 mg - Anti-human CTLA-8 / IL-17a (CAT-2200 Biosimilar) [orb2828615]
ELISA, FA, FACS, In vivo
Human
Monoclonal
Unconjugated
20 mg, 5 mg, 1 mg